NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

Infertility is defined as the inability of a couple to conceive naturally after one year of regular unprotected sexual intercourse. It remains a major clinical and social problem. The North America infertility testing and treatment market collected a net revenue of $XX million in 2018. Over the forecasted period of 2019-2027, the market is expected to exhibit a CAGR of 6.07%, collecting a net total of $XX million. The economies of the United States and Canada are mainly influencing the market growth in the region.

NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

North America Infertility Testing and Treatment Market by Male Infertility Testing and Treatment (Male Infertility Testing (Dna Fragmentation, Oxidative Stress Analysis, Sperm Penetration Assay, Computer Assisted Semen, Analysis (Casa), Sperm Agglutination, Microscopic Examination, Others), Male Infertility Treatment) by Female Infertility Testing and Treatment (Female Infertility Testing (Ovulation Testing, Hysterosalpingography, Laparoscopy, Transvaginal Ultrasound, Ovarian Reserve Testing, Hormonal Level Testing, Others (Genetic Testing)), Female Infertility Treatment) by End-users (Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) by Geography.

Request free sample

Infertility is defined as the inability of a couple to conceive naturally after one year of regular unprotected sexual intercourse. It remains a major clinical and social problem. The North America Infertility Testing and Treatment Market collected a net revenue of $XX million in 2018. Over the forecasted period of 2019-2027, the market is expected to exhibit a CAGR of 6.07%, collecting a net total of $XX million. The economies of the United States and Canada are mainly influencing the market growth in the region.

The most common cause of female infertility is the ovulatory problems which generally manifest on account of sparse or absent menstrual periods. Male infertility is most commonly due to deficiencies in the semen, and semen quality is used as a surrogate measure of male fecundity.

North America region has a minimal impact owing to the awareness of the contraception precautions and various government policies for healthcare such as affordable care act and so on. The growing use of various modern and traditional contraceptive drugs is increasing the concerns for infertility in the North America region.

The North American region witnessed about XX% infertility cases due to male factors; while female factors were responsible only in XX% cases. However, the rising use of contraceptive drugs is increasing infertility among the women population of North America. The U.S is the biggest market for infertility testing and treatment in this region, followed by Canada. It is estimated that up to xx% of couples in Canada experience infertility to some extent. However, the cost of these infertility treatments varies across both these regions.

The suppliers that are providing quality services and products by continuously investing in research and development are performing better by achieving a monopoly in the market. The major market players that are functioning in the region are extensively profiled in the report. Some of them are Irvine Scientific, Ferring Pharmaceuticals, Thermo Fisher Scientific Inc., Halotech DNA, Genea, Vitrolife AB, Endo Pharmaceuticals, Quest Diagnostic, Origio, Andrology Solutions, The Cooper Companies, Inc., Progyny, Esco Micro PTE. Ltd., Merck, and Ovascience.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • IVF DOMINATES THE FEMALE TREATMENT MARKET
      • OXIDATIVE STRESS ANALYSIS IS THE FASTEST GROWING MALE INFERTILITY TESTING MARKET
  1. MARKET OVERVIEW
    • MARKET DEFINITION
    • MARKET DRIVERS AND IMPACT
      • RISE IN INFERTILITY AND TREATMENT AWARENESS
      • MEDICAL TOURISM FOR FERTILITY TREATMENTS
      • SURROGACY LAWS ARE GETTING MORE DEFINED
      • HEALTHCARE ADVANCES HAVE FINETUNED FERTILITY TREATMENT
      • INCREASING EFFECTIVENESS OF TREATMENTS
      • HEALTHIER DONOR EGGS
      • INTRODUCTION OF NEW TESTING DEVICES
    • MARKET RESTRAINTS AND IMPACT
      • TREATMENT PROCEDURE OUT OF REACH TO MANY DUE TO COSTS INVOLVED
      • COUNTRY-WISE REGULATORY ISSUES
    • MARKET OPPORTUNITIES
      • REDUCING THE COST OF TREATMENT TO MAKE IT MORE ACCESSIBLE
      • IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
      • DIY TESTING INCREASING ACCESS AND REDUCING COST
    • MARKET CHALLENGES
      • INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
      • PERILS OF MULTIPLE PREGNANCIES
      • TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE FOR INFERTILITY TREATMENTS
        • DIET AND SUPPLEMENTS
        • ACUPUNCTURE
        • THERAPY
        • QIGONG
  1. INFERTILITY CAUSES
    • CAUSES OF MALE INFERTILITY
      • ABNORMALITY IN THE SPERM
      • ENVIRONMENTAL FACTORS
      • POOR HEALTH AND LIFESTYLE
    • CAUSES OF FEMALE INFERTILITY
      • OVULATION DISORDERS
      • DAMAGE TO FALLOPIAN TUBES
    • MORAL QUESTIONS
  2. MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY MALE INFERTILITY TESTING
      • DNA FRAGMENTATION
      • OXIDATIVE STRESS ANALYSIS
      • SPERM PENETRATION ASSAY
      • COMPUTER ASSISTED SEMEN ANALYSIS (CASA)
      • SPERM AGGLUTINATION
      • MICROSCOPIC EXAMINATION
      • OTHERS
    • MARKET BY MALE INFERTILITY TREATMENT
  1. FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY FEMALE INFERTILITY TESTING
      • OVULATION TESTING
      • HYSTEROSALPINGOGRAPHY
      • LAPAROSCOPY
      • TRANSVAGINAL ULTRASOUND
      • OVARIAN RESERVE TESTING
      • HORMONAL LEVEL TESTING
      • OTHERS (GENETIC TESTING)
    • MARKET BY FEMALE INFERTILITY TREATMENT
  1. NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. KEY ANALYTICS
    • PORTER’S 5 FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL PROCUREMENT
      • MANUFACTURING
      • SUPPLY LOGISTICS
      • DISTRIBUTION CHANNELS
      • END-USERS
    • KEY BUYING CRITERIA
      • TREATMENT OPTIONS
      • QUALITY OF MEDICAL PROCEDURES
      • PRICE OF TREATMENTS
      • SHIFT TOWARDS MEDICAL TOURISM
      • REIMBURSEMENT
    • REGULATORY FRAMEWORK
    • VENDOR LANDSCAPE
    • OPPORTUNITY MATRIX
  3. NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET COUNTRY ANALYSIS 2019-2027 ($ MILLION)
    • US
    • CANADA
  4. COMPANY PROFILES
    • ANDROLOGY SOLUTIONS
    • ENDO PHARMACEUTICALS
    • PROGYNY
    • FERRING PHARMACEUTICALS
    • GENEA
    • HALOTECH DNA
    • IRVINE SCIENTIFIC
    • MERCK
    • ORIGIO
    • OVASCIENCE
    • VITROLIFE AB
    • THERMO FISHER SCIENTIFIC INC.
    • THE COOPER COMPANIES, INC.
    • QUEST DIAGNOSTIC
    • ESCO MICRO PTE. LTD.

LIST OF TABLES

TABLE 1 NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET BY GENDER 2019-2027 ($ MILLION)

TABLE 2 AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 3 NORTH AMERICA MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 4 NORTH AMERICA MALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)

TABLE 5 PROS AND CONS OF DNA SHARING METHODS

TABLE 6 NORTH AMERICA FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 7 NORTH AMERICA FEMALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)

TABLE 8 COST OF OVULATION TESTING KITS IN THE US

TABLE 9 COST OF HORMONAL TEST IN THE US

TABLE 10 NORTH AMERICA FEMALE INFERTILITY TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 11 AVERAGE COST OF SOME INFERTILITY TREATMENTS

TABLE 12 SOME COMMON DRUG THERAPIES

TABLE 13 NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 14 NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 15 SUCCESS OF ASSISTED REPRODUCTIVE TECHNOLOGY (ART) USING DONOR EGGS IN THE U.S. IN 2013

TABLE 16 COSTS FOR INFERTILITY TREATMENTS IN THE U.S. 2015

TABLE 17 COST OF IVF & ICSI TREATMENT, CANADA 2014

LIST OF FIGURES

FIGURE 1 NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 2 MAJOR FERTILITY TREATMENT DESTINATION RANKING

FIGURE 3 CLINICAL ALGORITHM FOR THE EVALUATION OF INFERTILE WOMAN

FIGURE 4 RATE OF MULTIPLE DELIVERIES

FIGURE 5 CAUSES OF INFERTILITY

FIGURE 6 CAUSES OF INFERTILITY BASED ON GENDER

FIGURE 7 CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 8 NUMBER OF IVF CYCLES PERFORMED IN THE US

FIGURE 9 US INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 10 CANADA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

  1. NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET COUNTRY ANALYSIS 2019-2027 ($ MILLION)
    • US
    • CANADA
  2. MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY MALE INFERTILITY TESTING
      • DNA FRAGMENTATION
      • OXIDATIVE STRESS ANALYSIS
      • SPERM PENETRATION ASSAY
      • COMPUTER ASSISTED SEMEN ANALYSIS (CASA)
      • SPERM AGGLUTINATION
      • MICROSCOPIC EXAMINATION
      • OTHERS
    • MARKET BY MALE INFERTILITY TREATMENT
  1. FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY FEMALE INFERTILITY TESTING
      • OVULATION TESTING
      • HYSTEROSALPINGOGRAPHY
      • LAPAROSCOPY
      • TRANSVAGINAL ULTRASOUND
      • OVARIAN RESERVE TESTING
      • HORMONAL LEVEL TESTING
      • OTHERS (GENETIC TESTING)
    • MARKET BY FEMALE INFERTILITY TREATMENT
  1. NORTH AMERICA INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now